IDiyas

For the Inventor, By the Inventor

Grayslake, IL, United States of America

James F Kerwin

USPTO Granted Patents = 14

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 169(Granted Patents)


Location History:

  • Mundelein, IL (US) (1990 - 1994)
  • Grayslake, IL (US) (1994 - 2003)

Company Filing History:

goldMedal12 out of 4,177 
 
Abbott Laboratories Corporation
 patents
silverMedal2 out of 832,680 
Other
 patents

Years Active: 1990-2003

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6518279 - Cyclopentanone dihydropyridine compounds useful as potassium channel openers (2003-02-11),
2. 6503935 - Imidazoles and related compounds as &agr;1A agonists (2003-01-07),
3. 6046207 - Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds (2000-04-04),
4. 5891882 - Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic compounds (1999-04-06),
5. 5861294 - Adenosine kinase polypeptides (1999-01-19),
6. 5792767 - Bicyclic substituted hexahydrobenz �e! isoindole alpha-1 adrenergic (1998-08-11),
7. 5597823 - Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic (1997-01-28),
8. 5521181 - Bicyclic substituted hexahydrobenz[e]isoindole .alpha.-1 adrenergic (1996-05-28),
9. 5478946 - Guanidino compounds as regulators of nitric oxide synthase (1995-12-26),
10. 5380945 - Guanidino compounds as regulators of nitric oxide synthase (1995-01-10),
11. 5362747 - 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide (1994-11-08),
12. 5346907 - Amino acid analog CCK antagonists (1994-09-13),
13. 5128346 - Derivatives of D-glutamic acid and D-aspartic acid (1992-07-07),
14. 4971978 - Derivatives of D-glutamic acid and D-aspartic acid (1990-11-20),

Title: The Innovative Contributions of James F. Kerwin

Introduction

James F. Kerwin is a notable inventor based in Grayslake, Illinois. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the area of potassium channel opening.

Latest Patents

Among his latest patents are "Cyclopentanone dihydropyridine compounds useful as potassium channel openers" and "Imidazoles and related compounds as α1A agonists." These innovations reflect his commitment to advancing medical science and improving patient outcomes through novel chemical compounds.

Career Highlights

Throughout his career, James has worked with prominent organizations, including Abbott Laboratories Corporation. His experience in such a reputable company has allowed him to develop and refine his inventions, contributing to the advancement of pharmaceutical research.

Collaborations

James has collaborated with esteemed colleagues, including William A. Carroll and Michael D. Meyer. These partnerships have fostered a creative environment that has led to groundbreaking innovations in their respective fields.

Conclusion

James F. Kerwin's contributions to the field of pharmaceuticals through his numerous patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…